Trials / Completed
CompletedNCT05363488
Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland
A Retrospective Observational Research Study to Describe the Real World Use of Bosutinib in a Single Centre in Scotland
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 17 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will describe the efficacy and safety of bosutinib in patients with chronic myeloid leukaemia (CML) used in a real world clinical practice setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bosutinib | Patients receiving bosutinib treatment |
Timeline
- Start date
- 2021-10-08
- Primary completion
- 2021-10-08
- Completion
- 2021-10-08
- First posted
- 2022-05-06
- Last updated
- 2023-04-03
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05363488. Inclusion in this directory is not an endorsement.